Literature DB >> 19203910

Upper gastrointestinal bleeding may unmask didanosine-associated portal hepatopathy in HIV/HCV co-infected patients.

Eugenia Vispo1, Ivana Maida, Pablo Barreiro, Victoria Moreno, Vincent Soriano.   

Abstract

Three HIV individuals with chronic hepatitis C presented with esophageal variceal bleeding. They had mild liver fibrosis and normal liver function tests. All had received didanosine for long periods. Noncirrhotic portal hypertension associated with didanosine may appear in HIV patients without any liver disease or added to chronic hepatitis C.

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 19203910     DOI： 10.1310/hct0906-440

Source DB:  PubMed          Journal:  HIV Clin Trials        ISSN： 1528-4336


  4 in total

1.  Didanosine Exposure and Noncirrhotic Portal Hypertension in a HIV Clinic in North America: a Follow-up Study.

Authors:  Edward R Cachay; Michael R Peterson; Miguel Goicoechea; William C Mathews
Journal:  Br J Med Med Res       Date:  2011

2.  Human immunodeficiency virus infection and the liver.

Authors:  Megan Crane; David Iser; Sharon R Lewin
Journal:  World J Hepatol       Date:  2012-03-27

Review 3.  Update on HIV/HCV coinfection.

Authors:  Vincent Soriano; Eugenia Vispo; Jose Vicente Fernandez-Montero; Pablo Labarga; Pablo Barreiro
Journal:  Curr HIV/AIDS Rep       Date:  2013-09       Impact factor: 5.495

Review 4.  AIDS Clinical Research in Spain-Large HIV Population, Geniality of Doctors, and Missing Opportunities.

Authors:  Vicente Soriano; José M Ramos; Pablo Barreiro; Jose V Fernandez-Montero
Journal:  Viruses       Date:  2018-05-30       Impact factor: 5.048
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.